For the management of ST-segment elevation acute myocardial infarction (STEMI), international guidelines recommend primary percutaneous coronary intervention with adjunctive antithrombotic therapy, ...

A new study published in Clinical Cardiology introduces the North Indian (NORIN) ST‐Segment Elevation Myocardial Infarction (STEMI) Registry and provides preliminary data collected since its start in ...

CHICAGO -- Periprocedural anticoagulation with bivalirudin (Angiomax) for a radial-first approach to primary percutaneous coronary intervention (PCI) improved mortality and bleeding risk compared with ...

A new study from Denmark conducted over a 16-year period shows a 30% reduction in the 1-year mortality rate following percutaneous coronary intervention (PCI) for ST-segment elevation myocardial ...

Please provide your email address to receive an email when new articles are posted on . A comprehensive focus on STEMI care that includes transradial primary PCI, prompt guideline-directed medical ...

San Francisco, CA—Results of the randomized EUROMAX trial show that administering bivalirudin to STEMI patients en route to the hospital for primary PCI reduces the primary outcome of short-term death ...

February is Heart Health Awareness Month, and it is an opportune time to shed light on a critical issue that can affect rural communities like Humboldt County — the urgent need for STEMI (ST-Elevation ...

Morton Kern, MD, of VA Long Beach Healthcare System and University of California, Irvine, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in ...

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. “The mortality benefit of bivalirudin in STEMI patients ...

myocardial infarction, heart attack Even patients with advanced CKD or receiving dialysis appear to benefit from guideline-directed STEMI therapies, according to a retrospective study. Patients with ...